| CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
| 1209319-87-8 | 2-氧代-1-氧杂-3,9-二氮杂螺[5.5]十一烷-9-甲酸叔丁酯 | tert-butyl 2-oxo-1-oxa-3,9-diazaspiro[5.5]undecane-9-carboxylate | | | | |
| 1209335-53-4 | 4-溴-3-甲氧基吡啶盐酸盐 | 4-bromo-3-methoxypyridine hydrochloride | | | | |
| 120934-03-4 | 2,2,6-三氟苯并[1,3]二恶唑-5-基胺 | 2,2,6-trifluoro-benzo[1,3]dioxol-5-ylamine | | | | |
| 120934-10-3 | | 7-chloro-2,2,3,3-tetrafluoro-2,3-dihydro-benzo[1,4]dioxin-6-ylamine | | | | |
| 120934-96-5 | | fpl 64176 | | | | |
| 1209343-75-8 | | n-(2-chloroethyl)-1h-pyrazole-1-carboxamide | | | | |
| 120935-94-6 | 4-溴-2,5-二甲基-1h-吡咯-3-羧酸甲酯 | methyl 4-bromo-2,5-dimethyl-1h-pyrrole-3-carboxylate | | | | |
| 120937-44-2 | | di-tert-butylcyclopentadiene, mixture of isomers | C13H22 | 178.31 | | |
| 1209379-68-9 | 2,2'-((2-氰基乙酰基)氮杂二基)二乙酸二叔丁酯 | di-tert-butyl 2,2'-((2-cyanoacetyl)azanediyl)diacetate | | | | |
| 120939-52-8 | | n-butyl-aminopropyl-dimthoxymethyl-silane | C10H25NO2Si | 219.39 | | |
| 120940-43-4 | | n-methyl-n-[2-nitro-4-(trifluoromethyl)phenyl]hydrazine | C8H8F3N3O2 | 235.16 | 68-70℃ | |
| 120943-07-9 | | fmoc-pro-phe-oh | C2H28N2O5 | 160.25 | | |
| 120944-03-8 | | hnmpa-(am)3-cas 120944-03-8-calbiochem | | | | |
| 120944-08-3 | | 2(3h)-oxazolone, 4-(4-fluorophenyl)-5-(2-(4-(2-methylphenyl)-1-piperazinyl)ethy | | | | |
| 120944-09-4 | | 2(3h)-oxazolone, 4-(4-fluorophenyl)-5-(2-(4-(3-methylphenyl)-1-piperazinyl)ethy | | | | |
| 120944-10-7 | | 2(3h)-oxazolone, 4-(4-fluorophenyl)-5-(2-(4-(3-methoxyphenyl)-1-piperazinyl)eth | | | | |
| 120944-11-8 | | 2(3h)-oxazolone, 4-(4-fluorophenyl)-5-(2-(4-(4-methoxyphenyl)-1-piperazinyl)eth | | | | |
| 120944-12-9 | | 2(3h)-oxazolone, 4-(4-fluorophenyl)-5-(2-(4-(3-(trifluoromethyl)phenyl)-1-piper | | | | |
| 120944-13-0 | | 2(3h)-oxazolone, 5-(2-(4-(2-chlorophenyl)-1-piperazinyl)ethyl)-4-(4-fluoropheny | | | | |
| 120944-14-1 | | 2(3h)-oxazolone, 5-(2-(4-(3-chlorophenyl)-1-piperazinyl)ethyl)-4-(4-fluoropheny | | | | |
| 120944-15-2 | | 2(3h)-oxazolone, 5-(2-(4-(4-chlorophenyl)-1-piperazinyl)ethyl)-4-(4-fluoropheny | | | | |
| 120944-16-3 | | 2(3h)-oxazolone, 5-(2-(4-(2,5-dichlorophenyl)-1-piperazinyl)ethyl)-4-(4-fluorop | | | | |
| 120944-17-4 | | 2(3h)-oxazolone, 5-(2-(4-(3,4-dichlorophenyl)-1-piperazinyl)ethyl)-4-(4-fluorop | | | | |
| 120944-18-5 | | 2(3h)-oxazolone, 5-(2-(4-(3,5-dichlorophenyl)-1-piperazinyl)ethyl)-4-(4-fluorop | | | | |
| 120944-19-6 | | 2(3h)-oxazolone, 5-(2-(4-(2,4-dichlorophenyl)-1-piperazinyl)ethyl)-4-(4-fluorop | | | | |
| 120944-20-9 | | 2(3h)-oxazolone, 5-(2-(4-(2,3-dichlorophenyl)-1-piperazinyl)ethyl)-4-(4-fluorop | | | | |
| 120944-21-0 | | 2(3h)-oxazolone, 5-(2-(4-(3,5-dibromophenyl)-1-piperazinyl)ethyl)-4-(4-fluoroph | | | | |
| 120944-22-1 | | 4-(4-fluorophenyl)-5-(2-(4-(2,3,4-trichlorophenyl)-1-piperazinyl)ethyl)- 2(3h | | | | |
| 120944-23-2 | | 2(3h)-oxazolone, 4-(4-fluorophenyl)-5-(2-(4-(2,4,5-trichlorophenyl)-1-piperazin | | | | |
| 120944-24-3 | | 2(3h)-oxazolone, 4-(4-fluorophenyl)-5-(2-(4-(3,4,5-trichlorophenyl)-1-piperazin | | | | |
| 120944-25-4 | | 4-(4-chlorophenyl)-5-(2-(4-(2-pyridinyl)-1-piperazinyl)ethyl)-2(3h)-oxazolon | | | | |
| 120944-26-5 | | 4-(4-fluorophenyl)-5-(3-(4-phenyl-1-piperazinyl)propyl)-2(3h)-oxazolon mono | | | | |
| 120944-28-7 | | 4-(4-methylphenyl)-5-(2-(4-phenyl-1-piperazinyl)ethyl)-2(3h)-oxazolon (z)-2 | | | | |
| 120944-29-8 | | 4-(4-(methylthio)phenyl)-5-(2-(4-phenyl-1-piperazinyl)ethyl)-2(3h)-oxazolon | | | | |
| 120944-30-1 | | 4-(1,1'-biphenyl-4-yl)-5-(2-(4-phenyl-1-piperazinyl)ethyl)-2(3h)-oxazolon d | | | | |
| 120944-31-2 | | 4-(4-chlorophenyl)-5-((4-phenyl-1-piperazinyl)methyl)-2(3h)-oxazolon monohy | | | | |
| 120944-32-3 | | 2(3h)-oxazolone, 4-(4-fluorophenyl)-3-phenyl-5-(2-(4-phenyl-1-piperazinyl)ethyl | | | | |
| 120944-33-4 | | 3-acetyl-5-(2-(4-(3,5-dichlorophenyl)-1-piperazinyl)ethyl)-4-2(3h)-oxazolon | | | | |
| 120944-66-3 | | poly(oxy-1,2-ethanediyl), alpha, alpha'-(iminodi-2,1-ethanediyl)bis[ omega -(su | | | | |
| 120944-71-0 | | n-acetyl-met-asp-arg-val-leu-ser-*arg-tyr | C46H76N14O14S | 1081.25 | | |
| 120944-72-1 | | osteocalcin fragment 7-19 human | C65H98N16O19 | 1407.58 | | |
| 120944-74-3 | | n-succinyl-lys-asp-ser-ser-leu-tyr-pro- ala-leu-t | C72H109N15O25 | 1584.74 | | |
| 120944-75-4 | | boc-s-(4-methoxybenzyl)-l-penicillamine | C18H27NO5S | 369.47 | | |
| 120944-77-6 | | neocarrahexaose 24,41,43,45-tetra-*sulfate tetras | C36H52Na4O40S4 | 1344.98 | | |
| 120945-63-3 | | sodium tetrakis(3,5-bis(hexafluoro-2-me-thoxy-2- propyl)phe)b | C56H36BF48NaO8.3*H2O | 1836.66 | | |
| 1209457-90-8 | | n-benzyl-4-bromopyridin-2-amine | | | | |
| 1209458-03-6 | | 4-bromo-n-isopropylpyridin-2-amine | | | | |
| 1209458-06-9 | (6-溴吡嗪-2-基)甲醇 | (6-bromopyrazin-2-yl)methanol | | | | |
| 1209458-08-1 | | 2-bromopyrimidine-5-carbonitrile | | | | |
| 1209458-10-5 | 3-氯-n-环丙基吡嗪-2-胺 | 3-chloro-n-cyclopropylpyrazin-2-amine | | | | |
m.cnreagent.com